Analyst Ranking
Top 14%
#662 out of 4939 analysts
Average Return
+7.15%
Win Rate
40%68 out of 168
Risk vs Reward
Poor
Good

Laura Chico's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Longboard Pharmaceuticals IncLBPH
+658.28%$5.13$38.90
2023-10-12 -
2024-10-11
Buy
Edgewise Therapeutics IncEWTX
+560.25%$5.51$36.38
2023-11-10 -
2024-11-08
Buy
Vigil Neuroscience IncVIGL
+290.10%$2.02$7.88
2025-03-14 -
2025-05-22
Buy
Longboard Pharmaceuticals IncLBPH
+200.50%$19.96$59.98
2024-03-13 -
2024-11-29
Buy
Longboard Pharmaceuticals IncLBPH
+180.61%$21.38$59.98
2024-05-03 -
2024-11-29
Buy

Laura Chico Analyst Color

Get additional color on Laura Chico's coverage of popular stocks

Laura Chico's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Ultragenyx Pharmaceutical IncRARE
12Hold$34.00+16.32%Maintains
2 days ago
Maze Therapeutics IncMAZE
1Buy$17.00+8.01%Initiates Coverage On
8 days ago
Biocryst Pharmaceuticals IncBCRX
1Buy$18.00+100.89%Maintains
16 days ago
Larimar Therapeutics IncLRMR
2Buy$15.00+334.78%Maintains
22 days ago
Lennar CorpLEN
1Hold$130.00+15.16%Reiterates
a month ago
Biogen IncBIIB
15Hold$121.00-9.10%Reiterates
a month ago
Pharvaris NvPHVS
7Buy$27.00+13.45%Reiterates
a month ago
Vigil Neuroscience IncVIGL
11Hold$8.00-0.87%Downgrades
2 months ago
Travere Therapeutics IncTVTX
11Buy$30.00+77.41%Reiterates
2 months ago
Gossamer Bio IncGOSS
5Buy$4.00+161.44%Reiterates
2 months ago
Solid Biosciences IncSLDB
2Buy$17.00+210.79%Maintains
2 months ago
Jade Biosciences IncJBIO
5Buy$17.00+88.89%Reiterates
2 months ago
Alto Neuroscience IncANRO
4Hold$4.00+49.25%Reiterates
2 months ago
Vera Therapeutics IncVERA
8Hold$26.00+9.34%Maintains
2 months ago
Denali Therapeutics IncDNLI
8Buy$30.00+104.22%Maintains
2 months ago
Praxis Precision Medicines IncPRAX
7Sell$28.00-47.76%Maintains
2 months ago
Edgewise Therapeutics IncEWTX
10Buy$43.00+208.69%Maintains
3 months ago
Tourmaline Bio IncTRML
2Buy$43.00+126.79%Maintains
4 months ago
Ovid Therapeutics IncOVID
2Buy$3.00+655.67%Maintains
4 months ago
Dianthus Therapeutics IncDNTH
6Buy$36.00+79.73%Reiterates
4 months ago
Astria Therapeutics IncATXS
9Buy$28.00+322.96%Maintains
4 months ago
Apellis Pharmaceuticals IncAPLS
13Hold$29.00+45.66%Maintains
4 months ago
Sage Therapeutics IncSAGE
7Hold$6.00-34.43%Reiterates
5 months ago
Neurocrine Biosciences IncNBIX
9Buy$147.00+8.78%Maintains
5 months ago
Pepgen IncPEPG
10Buy$12.00+830.23%Maintains
8 months ago
Longboard Pharmaceuticals IncLBPH
7Buy$44.00-26.64%Maintains
10 months ago
Xenon Pharmaceuticals IncXENE
8Buy$49.00+50.31%Maintains
a year ago
Voyager Therapeutics IncVYGR
3Hold$7.00+104.08%Maintains
a year ago
Ardelyx IncARDX
13Buy$11.00+138.61%Reiterates
a year ago
Viridian Therapeutics IncVRDN
7Buy$42.00+145.04%Reiterates
a year ago
Stoke Therapeutics IncSTOK
6Buy$17.00N/AReiterates
a year ago
Rallybio CorpRLYB
4Buy$11.00N/AMaintains
a year ago
Design Therapeutics IncDSGN
5Hold$5.00N/AReiterates
a year ago
Karuna Therapeutics IncKRTX
4Hold$330.00N/ADowngrades
2 years ago
Chinook Therapeutics IncKDNY
3Hold$42.00N/ADowngrades
2 years ago
Impel Pharmaceuticals IncIMPLQ
2Hold$5.00N/ADowngrades
3 years ago
Taysha Gene Therapies IncTSHA
2Buy$5.00N/AMaintains
3 years ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
1Hold$148.50N/ADowngrades
3 years ago
Viela Bio IncVIE
2HoldN/AN/ADowngrades
4 years ago
Biomarin Pharmaceutical IncBMRN
3Buy$110.00N/AReinstates
6 years ago
Acer Therapeutics IncACER
2Buy$40.00N/AReinstates
6 years ago
Paratek Pharmaceuticals IncPRTK
2BuyN/AN/ADowngrades
7 years ago
Bioverativ IncBIVV
1HoldN/AN/ADowngrades
7 years ago
Corbus Pharmaceuticals Holdings IncCRBP
1Buy$720.00N/AInitiates Coverage On
7 years ago
Cidara Therapeutics IncCDTX
1Strong Buy$280.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.